Ozem­pic makes list for next round of Medicare drug price ne­go­ti­a­tions

No­vo Nordisk’s block­buster GLP-1 prod­ucts Ozem­pic and We­govy are among the next 15 drugs sub­ject to the gov­ern­ment’s Medicare ne­go­ti­a­tion pro­gram un­der the In­fla­tion Re­duc­tion …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER